Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Rheumatology

What Symptoms Can Rare Anti-KS, Anti-OJ, and Anti-Ha Cause?

At a Glance

Rare anti-KS, anti-OJ, anti-Ha, and anti-Zo antibodies may be associated with lung inflammation or scarring, muscle weakness, joint pain, Raynaud's phenomenon, and mechanic's hands. A positive antibody test alone does not diagnose Antisynthetase Syndrome.

A positive test for a rare antisynthetase antibody—like anti-KS, anti-OJ, anti-Ha, or anti-Zo—can support a diagnosis of Antisynthetase Syndrome (ASyS), but the blood test alone does not establish a diagnosis. Your diagnosis and what it means for your health will depend on your specific symptoms, physical exams, and other medical tests [1].

ASyS can involve a combination of lung inflammation, muscle inflammation, joint pain, Raynaud’s phenomenon (fingers changing color in the cold or under stress), and mechanic’s hands (rough, thickened, cracked skin on the sides of the fingers). However, small medical studies suggest that specific rare antibodies may lean toward certain symptom patterns [1].

Because these antibodies are uncommon, medical understanding is based on small observational studies and case reports rather than large clinical trials. The patterns described below are general tendencies observed in these small groups, not strict rules for how your individual illness will behave.

Anti-KS: More Often Associated With Lung Disease

Studies suggest anti-KS is highly associated with lung disease. In one review of small clinical groups, nearly all patients with anti-KS (up to 98%) had interstitial lung disease (ILD)—a group of conditions that cause inflammation and scarring in the lungs [2]. In fact, isolated ILD was reported as the only finding at the time of assessment for about half of these patients [2].

  • Muscles: Clinical muscle inflammation (myositis) was uncommon in these groups [2] [3].
  • Other Symptoms: Joint pain (arthritis) occurred in roughly a quarter of the reviewed patients. Mechanic’s hands and Raynaud’s phenomenon were also reported, though how often they appeared varied widely between different small studies [2].

Anti-OJ: Mixed Lung and Muscle Findings

Anti-OJ can involve clinically significant lung or muscle disease, but the severity varies from person to person.

  • Lungs: ILD is a prominent feature reported in anti-OJ groups [4] [5].
  • Muscles: Anti-OJ is frequently linked to severe myopathy (a general term for a muscle disorder, which in ASyS is often due to inflammation) [6] [7]. In some patients, severe muscle weakness was the first or even the only symptom reported [6] [8].
  • Other Symptoms: While arthritis and muscle involvement were reported slightly less often in an anti-OJ cohort compared to a group with the more common anti-Jo-1 antibody, they remain major features your doctor will watch for [4].

Anti-Ha and Anti-Zo: Very Rare Antibodies

These antibodies are extremely rare, so evidence comes from very small reports. They generally present with significant lung disease like other non-Jo-1 subtypes, but can involve the muscles as well.

  • Anti-Ha: Evidence on anti-Ha is limited and varies between case reports. Some reports describe patients with severe, rapidly progressive lung disease that initially appeared without any muscle signs [9] [10]. In contrast, a different retrospective series of 12 patients with isolated anti-Ha antibodies found that all 12 had clinical and microscopic evidence of muscle damage, and some also experienced Raynaud’s phenomenon [11]. Because these are separate, very small reports, they do not establish a single typical pattern.
  • Anti-Zo: In one small case series of just nine patients, lung and muscle involvement were reported equally (affecting 7 of the 9 patients) [12]. Joint pain, mechanic’s hands, and Raynaud’s phenomenon were also commonly noted in this tiny group [12].

What This Means for Your Care

The specific antibody pattern can help guide what your medical team watches for, but it does not by itself determine how severe your illness will be. A lung-associated antibody like anti-KS still requires baseline muscle testing, just as a mixed antibody like anti-OJ requires comprehensive lung evaluations (such as pulmonary function tests and imaging when clinically appropriate).

A rheumatologist familiar with ASyS can help coordinate your care, bringing in specialists like pulmonologists when lung symptoms or abnormal tests warrant it.

When to Seek Immediate Medical Help

Because ASyS can affect your breathing and swallowing, it is important to know which symptoms require urgent attention.

  • Seek urgent medical care (call 911 or go to an emergency room) if you experience severe or rapidly worsening shortness of breath, breathing difficulty at rest, blue or gray lips, fainting, chest pain, an inability to swallow, or rapidly progressive muscle weakness.
  • Contact your doctor’s office the same day for new breathlessness during exercise, a persistent new cough, or new noticeable weakness (such as trouble standing up from a chair). Do not wait for your next routine appointment to discuss new or worsening breathing problems.

Common questions in this guide

Does a positive anti-KS, anti-OJ, or anti-Ha result confirm Antisynthetase Syndrome?
No. These antibody results can support an evaluation for Antisynthetase Syndrome, but the diagnosis also depends on your symptoms, physical examination, and other tests. Because rare antibody tests may need confirmation, your clinician may discuss specialized laboratory validation.
What symptoms are most associated with anti-KS antibodies?
Small studies suggest anti-KS is strongly associated with interstitial lung disease, which may cause breathlessness or a persistent cough. Some people have lung disease without obvious muscle inflammation at first, but joint pain, Raynaud's phenomenon, and mechanic's hands can also occur. Your clinician may still check your muscles because antibody patterns do not rule out other features.
What can anti-OJ antibodies mean for my lungs and muscles?
Anti-OJ has been associated with both interstitial lung disease and muscle inflammation or weakness. In some reported patients, severe muscle weakness was the first or only noticeable symptom, while joint symptoms may also occur. The pattern and severity vary, so both lung and muscle evaluations are important.
What symptoms have been reported with anti-Ha or anti-Zo antibodies?
These antibodies are extremely rare, and the available reports do not show one consistent pattern. Anti-Ha has been reported with serious lung disease with or without muscle involvement, while small anti-Zo reports describe lung and muscle involvement along with joint pain, Raynaud's phenomenon, or mechanic's hands. Your clinician should interpret these findings in context.
When should I seek emergency care with these antibodies?
Call 911 or go to an emergency department for severe or rapidly worsening shortness of breath, breathing difficulty at rest, blue or gray lips, fainting, chest pain, inability to swallow, or rapidly progressive muscle weakness. Contact your doctor's office the same day for new breathlessness with activity, a persistent new cough, or new noticeable weakness. Do not wait for routine follow-up if breathing or swallowing worsens.
What tests and specialists may be part of follow-up?
A rheumatologist may coordinate care, with a pulmonologist involved if lung symptoms or abnormal tests suggest lung disease. Baseline muscle testing and lung evaluation, such as pulmonary function tests and imaging when clinically appropriate, may be used to guide monitoring. The timing of repeat tests depends on your symptoms and clinical findings.

Get notified when new evidence is published on Antisynthetase syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Antisynthetase syndrome: a review of etiopathogenesis, diagnosis and management.

    Mirrakhimov AE

    Current medicinal chemistry 2015; (22(16)):1963 - 75.

    PMID: 25973980
  2. 2

    Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome.

    Ge Y, Li S, Li S, et al.

    Therapeutic advances in chronic disease 2020; (11()):2040622320968417 doi:10.1177/2040622320968417.

    PMID: 33194166
  3. 3

    New aspects of clinical and immunological characteristics in patients with anti-asparaginyl tRNA synthetase (anti-KS) autoantibody.

    Hosono Y, Ishii A, Izumi Y, et al.

    Modern rheumatology 2023; (34(1)):122-128 doi:10.1093/mr/road011.

    PMID: 36691996
  4. 4

    Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature review.

    Pillot V, Toquet S, Charuel JL, et al.

    Autoimmunity reviews 2026; (25(4)):104032 doi:10.1016/j.autrev.2026.104032.

    PMID: 41825679
  5. 5

    Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.

    Jiang M, Dong X, Zheng Y

    Medicine 2021; (100(19)):e25816 doi:10.1097/MD.0000000000025816.

    PMID: 34106621
  6. 6

    Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China.

    Wang R, Zhao Y, Qi F, et al.

    Clinical rheumatology 2023; (42(3)):703-709 doi:10.1007/s10067-022-06404-8.

    PMID: 36308573
  7. 7

    Skeletal Muscle Involvement in Antisynthetase Syndrome.

    Noguchi E, Uruha A, Suzuki S, et al.

    JAMA neurology 2017; (74(8)):992-999 doi:10.1001/jamaneurol.2017.0934.

    PMID: 28586844
  8. 8

    Novel case of anti-synthetase syndrome.

    Kapoor A, Vaidyan P, Jalil B, Upaluri C

    European journal of rheumatology 2018; (5(4)):275-277 doi:10.5152/eurjrheum.2018.17167.

    PMID: 30071936
  9. 9

    Anti-Ha anti-synthetase syndrome presenting as rapidly progressive interstitial lung disease: a case report of high confidence autoantibody testing.

    Liedtke AG, Daikeler T, Gherca S, et al.

    Frontiers in immunology 2026; (17()):1750916 doi:10.3389/fimmu.2026.1750916.

    PMID: 41836427
  10. 10

    Acute exacerbation of anti-Ha antibody-positive antisynthetase syndrome-associated interstitial lung disease: a case report.

    Li Y, Ke J, Huang S, et al.

    Frontiers in immunology 2025; (16()):1614777 doi:10.3389/fimmu.2025.1614777.

    PMID: 40574857
  11. 11

    Clinico-sero-pathological characteristics of anti-Ha antisynthetase syndrome.

    Zhao B, Hou Y, Shao K, et al.

    Brain pathology (Zurich, Switzerland) 2025; (35(3)):e13319 doi:10.1111/bpa.13319.

    PMID: 39557603
  12. 12

    The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients.

    Tansley SL, Betteridge Z, Lu H, et al.

    Rheumatology (Oxford, England) 2020; (59(7)):1626-1631 doi:10.1093/rheumatology/kez504.

    PMID: 31665469

This page is for informational purposes only and does not constitute medical advice; it describes reported symptom patterns but cannot diagnose Antisynthetase Syndrome or predict your individual course. Discuss your antibody results and any new breathing, swallowing, or muscle symptoms with your healthcare team.